At the time of writing, Immunocore Holdings plc ADR [IMCR] stock is trading at $35.29, up 5.88%. An important factor to consider is whether the stock is rising or falling in short-term value. The IMCR shares have gain 9.26% over the last week, with a monthly amount drifted -1.70%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Immunocore Holdings plc ADR [NASDAQ: IMCR] stock has seen the most recent analyst activity on January 07, 2026, when UBS upgraded its rating to a Buy but kept the price target unchanged to $55 for it. Previously, Wells Fargo started tracking the stock with Overweight rating on October 31, 2025, and set its price target to $60. Deutsche Bank initiated its recommendation with a Buy and recommended $65 as its price target on May 27, 2025. Morgan Stanley downgraded its rating to Equal-Weight for this stock on December 13, 2024, and downed its price target to $35. In a note dated November 11, 2024, Mizuho downgraded an Neutral rating on this stock and revised its target price from $72 to $38.
For the past year, the stock price of Immunocore Holdings plc ADR fluctuated between $23.15 and $40.71. Currently, Wall Street analysts expect the stock to reach $50.33 within the next 12 months. Immunocore Holdings plc ADR [NASDAQ: IMCR] shares were valued at $35.29 at the most recent close of the market. An investor can expect a potential return of 42.62% based on the average IMCR price forecast.
Analyzing the IMCR fundamentals
According to Immunocore Holdings plc ADR [NASDAQ:IMCR], the company’s sales were 379.71M for trailing twelve months, which represents an 27.14% jump. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.07 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Immunocore Holdings plc ADR [NASDAQ:IMCR] has a current ratio of 6.00. On the other hand, the Quick Ratio is 5.97, and the Cash Ratio is 2.93. Considering the valuation of this stock, the price to sales ratio is 4.69, the price to book ratio is 4.52.
Transactions by insiders
Recent insider trading involved Berman David M, HEAD OF R&D, that happened on Dec 04 ’25 when 31341.0 shares were sold. HEAD OF R&D, Berman David M completed a deal on Dec 05 ’25 to sell 572.0 shares. Meanwhile, HEAD OF R&D Berman David M sold 69404.0 shares on Nov 26 ’25.
